ARTIVION, INC. Cash and Restricted Cash
ARTIVION, INC. (AORT) had Cash and Restricted Cash of $77.32 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $77.32M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $55.76M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $64.91M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $73.43M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $77.32M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $55.76M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $64.91M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $73.43M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $53.48M 10-Q · filed 2026-08-07 |
| 2025-03-31 | $37.69M 10-Q · filed 2026-05-08 |
| 2024-12-31 | $53.46M 10-Q · filed 2026-08-07 |
| 2024-09-30 | $56.17M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $55.02M 10-Q · filed 2025-08-08 |
| 2024-03-31 | $51.12M 10-Q · filed 2025-05-06 |
| 2023-12-31 | $58.94M 10-K · filed 2026-02-18 |
| 2023-09-30 | $53.48M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $48.77M 10-Q · filed 2024-08-09 |
| 2023-03-31 | $30.77M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $39.35M 10-K · filed 2026-02-18 |
| 2022-09-30 | $37.57M 10-Q · filed 2023-11-03 |
| 2022-06-30 | $40.38M 10-Q · filed 2023-08-04 |
| 2022-03-31 | $51.41M 10-Q · filed 2023-05-05 |
| 2021-12-31 | $55.01M 10-K · filed 2025-02-28 |
| 2021-09-30 | $65.13M 10-Q · filed 2022-11-04 |
| 2021-06-30 | $51.03M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $57.10M 10-Q · filed 2022-05-06 |
| 2020-12-31 | $61.96M 10-K · filed 2024-02-23 |
| 2020-09-30 | $64.64M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $126.12M 10-Q · filed 2021-07-30 |
| 2020-03-31 | $63.88M 10-Q · filed 2021-04-30 |
| 2019-12-31 | $34.29M 10-K · filed 2023-02-23 |
| 2019-09-30 | $37.18M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $40.26M 10-Q · filed 2020-07-31 |
| 2019-03-31 | $41.08M 10-Q · filed 2020-05-01 |
| 2018-12-31 | $42.24M 10-K · filed 2022-02-22 |
| 2018-09-30 | $35.31M 10-Q · filed 2019-10-31 |
| 2018-06-30 | $25.72M 10-Q · filed 2019-07-31 |
| 2018-03-31 | $27.39M 10-Q · filed 2019-05-02 |
| 2017-12-31 | $40.75M 10-K · filed 2021-02-23 |
| 2017-09-30 | $55.01M 10-Q · filed 2018-11-01 |
| 2017-06-30 | $52.51M 10-Q · filed 2018-08-07 |
| 2017-03-31 | $59.59M 10-Q · filed 2018-05-04 |
| 2016-12-31 | $57.34M 10-K · filed 2020-02-19 |
| 2015-12-31 | $43.42M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |